✦ LIBER ✦

Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms

✍ Scribed by M. Gniadkowski

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 155 KB
Volume: 7
Category: Article
ISSN: 1198-743X
DOI: 10.1046/j.1198-743x.2001.00330.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Substrate specificity of HMRZ-86 for β-l

Substrate specificity of HMRZ-86 for β-lactamases, including extended-spectrum β-lactamases (ESBLs)

✍ Hideaki Hanaki; Yuuji Koide; Hiroaki Yamazaki; Ryoichi Kubo; Tomota Nakano; Koic 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 401 KB

Wild boars as reservoirs of extended-spe

Wild boars as reservoirs of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli of different phylogenetic groups

✍ Patrícia Poeta; Hajer Radhouani; Luís Pinto; António Martinho; Vítor Rego; Rogér 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

## Abstract ESBL‐producing __E. coli__ isolates have been isolated from eight of seventy seven faecal samples (10.4%) of wild boars in Portugal. The ESBL types identified by PCR and sequencing were __bla__~CTX‐M‐1~ (6 isolates) and __bla__~CTX‐M‐1~ + __bla__~TEM1‐b~ (2 isolates). Further resistance

Trends of methicillin-resistantStaphyloc

Trends of methicillin-resistantStaphylococcus aureus(MRSA) andEnterobacteriaceae-producing extended-spectrum β-lactamase (ESBLE) in eastern France: a three-year multi-centre incidence study

✍ X. Bertrand; L. Mouchot; M. Jebabli; O. Bajolet; S. Aho; M.-F. Blech; C. Eloy; N 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 119 KB

Evaluation of the VITEK 2 AST-N111 card

Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) inEscherichia coli, Klebsiella pneumoniae,andKlebsiella oxytocacompared to ESBL Etests and combination disk methods

✍ G. Valenza; S. Müller; C. Schmitt; D. Turnwald; T-T. Lam; M. Frosch; M. Abele-Ho 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 91 KB

Risk factors for, and clinical relevance

Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producingEscherichia coli(ESBL-EC) carriage in neutropenic patients with haematological malignancies

✍ M. Arnan; C. Gudiol; L. Calatayud; J. Liñares; M. Á. Dominguez; M. Batlle; J. M. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 161 KB

Prevalence of extended-spectrum β-lactam

Prevalence of extended-spectrum β-lactamases in group-1 β-lactamase-producing isolates

✍ C. Varela; A. Oliver; T. M. Coque; F. Baquero; R. Cantón 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB